Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Giannoni
Design of Donecopride, a Dual Serotonin Subtype 4 Receptor Agonist/Acetylcholinesterase Inhibitor With Potential Interest for Alzheimer's Disease Treatment
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Exposure to Reversine Affects the Chondrocyte Morphology and Phenotype in Vitro
Journal of Tissue Engineering and Regenerative Medicine
Medicine
Biomedical Engineering
Biomaterials
Related publications
New Tacrine−Huperzine a Hybrids (Huprines): Highly Potent Tight-Binding Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer's Disease
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
Frontiers in Pharmacology
Pharmacology
Role of Prucalopride, a Serotonin (5-Ht4) Receptor Agonist, for the Treatment of Chronic Constipation
Clinical and Experimental Gastroenterology
Gastroenterology
Transition Metal Chelator Therapy - A Potential Treatment for Alzheimer's Disease?
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Characterization of a Temporoparietal Junction Subtype of Alzheimer's Disease
Human Brain Mapping
Nuclear Medicine
Radiology
Ultrasound Technology
Anatomy
Radiological
Neurology
Imaging
Potential Repurposing of Oncology Drugs for the Treatment of Alzheimer's Disease
BMC Medicine
Medicine
An Immunohistochemical Study of the Serotonin 1A Receptor in the Hippocampus of Subjects With Alzheimer's Disease
Neuropathology
Medicine
Forensic Medicine
Pathology
Neurology
Allosteric Modulation of the M1 Muscarinic Acetylcholine Receptor: Improving Cognition and a Potential Treatment for Schizophrenia and Alzheimer's Disease
Drug Discovery Today
Drug Discovery
Pharmacology
Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2c Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive–Compulsive Disorder
Frontiers in Psychiatry
Psychiatry
Mental Health
